MCM
DPLO

Mainstay Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Mainstay Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,265
Closed -$141K – 410
2018
Q3 		$141K Buy
7,265
+100
+1% +$2.13K 0.09% 117
2018
Q2 		$183K Buy
7,165
+550
+8% +$12.8K 0.14% 91
2018
Q1 		$133K Sell
6,615
-625
-9% -$14.6K 0.1% 102
2017
Q4 		$145K Buy
+7,240
New +$142K 0.12% 106

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mainstay Capital Management's DPLO Position: Q4 2018 in Review

Mainstay Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2018, closing a stake of 7,265 shares — an estimated $141K sold.

Mainstay Capital Management first reported a position in DPLO in Q4 2017 and held it in 4 quarters. The position peaked at $183K in Q2 2018. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

  • Mainstay Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2018 after selling out during the quarter.
  • Mainstay Capital Management sold 7,265 DIPLOMAT PHARMACY, INC. shares in Q4 2018, an estimated $141K.
  • Mainstay Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 4 quarters.
  • Mainstay Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $183K in Q2 2018.
  • 157 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2018.

Based on Mainstay Capital Management's 13F filing for Q4 2018, filed 8 Feb 2019.